Profile data is unavailable for this security.
About the company
Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. It is focused on the repair, regeneration and replacement of soft and hard tissue. The Company operates through three segments: Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip and knee Implants used to replace diseased, damaged or worn joints, robotics-assisted and digital enabling technologies and services that helps surgeons, and trauma products used to stabilize severe fractures and correct hard tissue deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue. Its Advanced Wound Management portfolio provides a comprehensive set of products to meet broad and complex clinical needs, and to help healthcare professionals reduce the human and economic consequences of wounds.
- Revenue in USD (TTM)5.21bn
- Net income in USD496.00m
- Incorporated1937
- Employees18.00k
- LocationSmith & Nephew PLCBuilding 5, Croxley Park, Hatters LaneWATFORD WD18 8YEUnited KingdomGBR
- Phone+44 207 401 7646
- Fax+44 207 930 3353
- Websitehttps://www.smith-nephew.com/
More ▼
Mergers & acquisitions
| Acquired company | SN.:LSE since announced | Transaction value |
|---|---|---|
| Engage Surgical | -12.28% | 135.00m |
Data delayed at least 20 minutes, as of Dec 02 2022 16:45 GMT.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DENTSPLY SIRONA Inc | 4.01bn | -843.00m | 6.81bn | 15.00k | -- | 1.88 | -- | 1.70 | -3.94 | -3.94 | 18.49 | 16.81 | 0.4767 | 3.23 | 5.75 | 267,133.30 | -10.03 | -4.12 | -11.72 | -4.64 | 54.63 | 53.59 | -21.04 | -9.97 | 1.04 | 6.00 | 0.3543 | -- | 26.71 | 2.47 | 663.01 | -0.8952 | 2.40 | 6.76 |
| Inspire Medical Systems Inc | 348.35m | -50.42m | 6.92bn | 485.00 | -- | 14.68 | -- | 19.86 | -1.82 | -1.82 | 12.59 | 16.31 | 0.864 | 3.59 | 9.27 | 718,255.70 | -12.51 | -20.41 | -13.94 | -22.56 | 84.18 | 84.19 | -14.47 | -33.69 | 9.75 | -94.56 | 0.00 | -- | 102.28 | 70.02 | 26.50 | -- | 72.46 | -- |
| Globus Medical Inc | 998.37m | 155.21m | 7.48bn | 2.40k | 49.39 | 4.24 | 33.50 | 7.50 | 1.52 | 1.52 | 9.72 | 17.67 | 0.5137 | 0.9866 | 5.46 | 415,985.80 | 7.99 | 9.69 | 8.58 | 10.48 | 74.47 | 75.61 | 15.55 | 17.56 | 4.39 | -- | 0.00 | 0.00 | 21.43 | 11.18 | 45.86 | 7.41 | 6.82 | -- |
| Masimo Corp | 1.75bn | 170.85m | 7.65bn | 2.20k | 48.14 | 6.11 | 27.04 | 4.38 | 3.02 | 3.02 | 31.12 | 23.83 | 0.7242 | 2.25 | 6.18 | 793,826.80 | 7.08 | 16.30 | 8.53 | 19.00 | 54.99 | 65.96 | 9.78 | 21.40 | 1.28 | -- | 0.4352 | 0.00 | 8.34 | 11.69 | -4.43 | -5.89 | 7.48 | -- |
| Penumbra Inc | 829.93m | -30.51m | 8.01bn | 3.80k | -- | 8.22 | -- | 9.65 | -0.8131 | -0.8131 | 21.86 | 25.65 | 0.7233 | 1.06 | 5.37 | 218,402.10 | -2.66 | 1.85 | -2.98 | 2.11 | 62.92 | 64.36 | -3.68 | 2.29 | 2.92 | -156.79 | 0.0272 | 0.00 | 33.40 | 23.21 | 133.65 | -18.63 | 9.21 | -- |
| Shockwave Medical Inc | 429.89m | 88.03m | 9.03bn | 657.00 | 106.22 | 25.37 | 97.92 | 21.01 | 2.35 | 2.35 | 11.57 | 9.85 | 1.11 | 1.12 | 9.13 | 654,322.70 | 22.72 | -- | 25.88 | -- | 86.01 | -- | 20.48 | -- | 6.02 | 31.34 | 0.0401 | -- | 249.83 | -- | 86.09 | -- | -- | -- |
| Henry Schein, Inc. | 12.61bn | 638.23m | 11.29bn | 21.60k | 18.13 | 3.12 | 12.96 | 0.8956 | 4.59 | 4.59 | 90.74 | 26.70 | 1.49 | 4.88 | 8.24 | 583,635.30 | 7.70 | 6.27 | 12.99 | 11.21 | 30.23 | 29.99 | 5.18 | 4.80 | 0.9967 | 36.38 | 0.1785 | 0.00 | 22.55 | 1.39 | 56.71 | 4.49 | 2.40 | -- |
| Teleflex Incorporated | 2.79bn | 412.27m | 11.38bn | 14.00k | 27.87 | 2.92 | 17.73 | 4.07 | 8.71 | 8.71 | 59.02 | 83.04 | 0.4051 | 2.50 | 7.07 | 199,639.90 | 5.98 | 5.57 | 6.53 | 6.10 | 54.70 | 55.22 | 14.75 | 13.90 | 1.52 | 11.29 | 0.3048 | 17.97 | 10.74 | 8.51 | 44.47 | 15.39 | 6.15 | 0.00 |
| Smith & Nephew plc (ADR) | 5.21bn | 496.00m | 11.66bn | 18.00k | 24.04 | 2.20 | 10.81 | 2.24 | 1.13 | 1.13 | 11.89 | 12.37 | 0.4956 | 0.8075 | 4.13 | 283,793.30 | 4.72 | 6.69 | 5.90 | 8.08 | 71.03 | 72.54 | 9.51 | 12.34 | 0.8356 | 7.99 | 0.3491 | 52.90 | 14.30 | 2.22 | 16.96 | -7.74 | 0.8033 | -- |
| Align Technology, Inc. | 3.86bn | 510.76m | 15.50bn | 22.54k | 30.72 | 4.19 | 24.51 | 4.01 | 6.46 | 6.46 | 48.97 | 47.30 | 0.6684 | 4.18 | 4.51 | 171,438.30 | 8.83 | 25.12 | 12.83 | 36.50 | 71.44 | 73.40 | 13.22 | 30.36 | 1.20 | -- | 0.00 | 0.00 | 59.90 | 29.63 | -56.53 | 32.41 | 41.55 | -- |
| Cooper Companies Inc | 3.22bn | 430.60m | 15.91bn | 12.00k | 37.29 | 2.24 | 20.79 | 4.94 | 8.64 | 8.64 | 64.62 | 143.67 | 0.3043 | 1.84 | 5.97 | 268,291.70 | 4.07 | 14.09 | 4.60 | 15.99 | 65.38 | 65.03 | 13.37 | 34.48 | 0.7095 | 63.36 | 0.2892 | 0.3386 | 20.22 | 8.24 | 1,135.19 | 60.80 | 7.03 | 0.00 |
| ABIOMED Inc | 1.07bn | 266.76m | 17.01bn | 2.00k | 64.83 | 11.07 | 57.79 | 15.84 | 5.82 | 5.82 | 23.41 | 34.09 | 0.6658 | 2.13 | 11.67 | 536,243.60 | 16.54 | 16.91 | 17.91 | 18.75 | 81.32 | 82.13 | 24.84 | 23.45 | 7.17 | -- | 0.00 | 0.00 | 21.74 | 18.30 | -39.47 | 21.24 | -6.64 | -- |
Data as of Dec 03 2022. Currency figures normalised to Smith & Nephew PLC's reporting currency: US Dollar USD
6.62%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Nuance Investments LLCas of 30 Sep 2022 | 13.10m | 3.01% |
| Fiduciary Management, Inc.as of 30 Sep 2022 | 6.99m | 1.61% |
| Scharf Investments LLCas of 30 Sep 2022 | 2.07m | 0.48% |
| Arrowstreet Capital LPas of 30 Sep 2022 | 1.74m | 0.40% |
| Raymond James & Associates, Inc. (Invt Mgmt)as of 30 Sep 2022 | 1.06m | 0.24% |
| Magnetar Financial LLCas of 30 Sep 2022 | 820.46k | 0.19% |
| Fidelity Management & Research Co. LLCas of 30 Sep 2022 | 777.44k | 0.18% |
| Parametric Portfolio Associates LLCas of 30 Sep 2022 | 766.06k | 0.18% |
| Strategic Advisers LLCas of 30 Sep 2022 | 763.35k | 0.18% |
| Goldman Sachs Asset Management LPas of 30 Sep 2022 | 748.82k | 0.17% |
More ▼
Data from 30 Sep 2022 - 30 Sep 2022Source: FactSet Research Systems Inc.
